控制释放技术

综述药物控制释放的种类，机理，高分子材料在控制释放技术中的应用。     

高分子包囊药物释放体系

用高分子作为载体的高分子微包囊和纳米级包囊药物制剂不仅能控制药物以一定的速度释放，而且可对生物体的生理指标变化作出反馈，因而可以成为靶向药物释放体系。通过用高分子包囊还可以延长蛋白质和多肽类药物的生理活性，提高药物稳定性，使之成为长效药物，并使一些难以口服的药物能够制成口服制剂。文章在介绍有关高分子药物释放体系的一些基本原理，以及与之相关的药学、药理学、物理化学和高分子材料科学方面知识的基础上，较全面地综述了高分子包囊药物的制备技术和应用。阐述了高分子包囊的粒径、表面积、孔度、药物性能和药含量，以及高分子包囊材料的性能对药物释放行为的影响。对药物传送机理亦进行了扼要的介绍。     

高分子生物材料分子工程研究进展（上）

分子工程研究是生物材料发展的根本途径和必由之路。本文论述了近４０多年来高分子材料分子工程的研究主要进展，其中包括材料的抗凝血性、的组织相容性、材料表面的生物功能化和生物智能化、体内稳定高分子、体内可吸收高分子以及药物的控制释放。     

生物可降解聚磷酸酯的合成及其释药性能研究

生物可降解聚磷酸酯的合成及其释药性能研究罗毅，卓仁禧，范昌烈（武汉大学化学系，武汉，４３００７２）关键词聚磷酸酯，５－氟尿嘧啶，药物控制释放高分子控制释放材料的研究、发展及其在药物制剂中的应用对提高药物的持续性和专一性研究产生了突破，通过控制释放材料...     

高分子药物及载体材料

高分子药物由于具有良好的生物降解性和生物相容性,可以控制药物释放速度,能够降低药物的毒副作用,减少抗药性,提高药物的稳定性和有效利用率,从而引起国内外广泛关注.本文从自身具有药理活性的高分子、高分子载体药物两个方面综述了近年来高分子药物及载体材料的研究进展.按化学结合力不同将高分子载体药物分为高分子前药和高分子络合物药...     

药物控制释放用天然多糖载体的制备技术研究进展

药物的控制释放体系是生物医用材料研究领域的重要课题,其支撑点是要有性能良好的高分子药物载体。由于天然多糖作为药物控制释放材料具有比合成聚合物更多的优势,因而一直是国内外学者研究的重点。文章从微球与胶囊、水凝胶、压缩膜三方面分别对天然多糖药物载体的制备技术进行了简述,并提出了多糖研究中存在的主要问题和今后的研究重点。     

药用合成高分子缓、控释材料研究进展

药物的缓、控释材料可以实现药物的平稳长期的释放,同时使药物治疗达到有的放矢的效果,高分子材料是制作药物缓控释材料的重要材料,包括天然高分子与合成高分子两大类。其中,天然高分子用作药物缓控释材料的研究已有多年的历史,已为人们所熟知。本文主要综述药用合成高分子缓、控释材料研究进展,分析了不同缓、控释材料的制备方法、释药原理和适用药物,为合成新型药用缓、控释材料,扩大药用缓、控释高分子材料的应用范围提供依据。     

高分子前药研究进展

高分子前药可以控制药物释放速度,降低小分子药物的毒副作用,减少抗药性,增强抗肿瘤药物的靶向性和选择性,提高多肽、蛋白质和核酸类药物的稳定性和有效利用率,引起国内外广泛关注.本文综述了近年来高分子药物的研究进展,主要从高分子载体材料的选择与改性对载药量、生物相容性和肾排泄的影响,以及化学合成过程中载体和药物末端的修饰、空...     

药物微胶囊壁材研究进展

药物微胶囊在药物的缓控释放等方面有着广阔的应用前景,因而近年来正成为农药、医药新剂型领域研究的热点之一。开发有竞争力的微胶囊壁材是当前药物微胶囊研究领域的一个重要课题。本文从天然高分子材料、全合成高分子材料、半合成高分子材料及无机材料4个方面综述了药物微胶囊壁材研究与应用的最新进展,着重阐述了明胶-阿拉伯胶、壳聚糖-海藻酸钠、环糊精及其衍生物、聚乳酸及其共聚物、脂肪族聚碳酸酯等生物可降解高分子材料作为药物微胶囊壁材的研究进展。     

聚天冬酰胺键合布洛芬共价复合体的合成

聚天冬酰胺类高分子材料,以其生物相容性好,毒性低,合成路线简单,且易与药物键合,被认为是一类有相当前景的药物控制释放材料,已引起国内外学者的极大兴趣［１,２］。课题组已对该材料进行了多年的研究,成功地将乙酰水杨酸、炔诺酮等多种药物键合于该材料上［３－...     

Yoctowell Cavities on Magnetic Silica Nanoparticles for pH Stimuli‐Responsive Controlled Release of Drug Molecules

Drug‐delivery systems that medically transport active molecules to diseased cells, in a controlled manner, have gained much attention in recent years. Yoctowell (1 yL=8 nm³ that is, 10^?24 L volume) cavities on magnetic silica nanoparticles were used for the encapsulation and release of the drug molecule, “mitoxantrone ( MTZ )”, and controlled using naturally occurring stimuli, that is, pH. First, MTZ was encapsulated from a bulk solution under physiological conditions, and then released from the yoctowells, in a controlled manner, by manipulating the pH (7.2–3.0). The sustained release of MTZ , the recovery of active yoctowells after the release process and magnetic properties of nanoparticles provide potential for development of a new generation of drug‐delivery system.     

基于天然高分子基元的阻隔层对磁性载药聚乳酸微球的控释作用

利用层层组装技术构建了基于天然高分子壳聚糖和海藻酸钠的阻隔层, 并研究了该阻隔层对磁性载药聚乳酸微球的药物释放作用. 实验结果表明, 阻隔层能够有效抑制模型药物的突释, 具有延缓药物释放的效果. 具有阻隔层的磁性载药体系具有药物释放平缓和生物相容性高等特点, 是理想的磁靶向载药体系.     

Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents

In the present study, the different drug-eluting controlled biodegradable polymer coatings were fabricated on stainless steel stents. The coatings were not only uniform and smooth but also had excellent mechanical property. The drug release profiles of drug-eluting stents were studied in detail in this study. Depending on the drug type, different drug-eluting stents exhibited different drug release profile. There were two basic release profiles for different drug-eluting stents, i.e., two-phase release profile with burst release or linear release profile without burst release. Incorporating heparin in the rapamycin or curcumin eluting stents can improve the average drug release rate of both and the burst release of rapamycin. The average drug release rate increased with the increase of drug loading but was not proportional to increase of the ratio of drug/polymer. Fabricating the control release layer on rapamycin-eluting stent surface can prevent the burst release of rapamycin and prolong the release period of rapamycin. All results showed that the drug release profile of drug-eluting stents depends on many parameters including drug type, ratio of drug/polymer, and drug carrier properties.     

Magnetic Resonance Methods as a Prognostic Tool for the Biorelevant Behavior of Xanthan Tablets

Hydrophilic matrix tablets with controlled drug release have been used extensively as one of the most successful oral drug delivery systems for optimizing therapeutic efficacy. In this work, magnetic resonance imaging (MRI) is used to study the influence of various pHs and mechanical stresses caused by medium flow (at rest, 80, or 150 mL/min) on swelling and on pentoxifylline release from xanthan (Xan) tablets. Moreover, a bimodal MRI system with simultaneous release testing enables measurements of hydrogel thickness and drug release, both under the same experimental conditions and at the same time. The results show that in water, the hydrogel structure is weaker and less resistant to erosion than the Xan structure in the acid medium. Different hydrogel structures affect drug release with erosion controlled release in water and diffusion controlled release in the acid medium. Mechanical stress simulating gastrointestinal contraction has no effect on the hard hydrogel in the acid medium where the release is independent of the tested stress, while it affects the release from the weak hydrogel in water with faster release under high stress. Our findings suggest that simultaneous MR imaging and drug release from matrix tablets together provide a valuable prognostic tool for prolonged drug delivery design.     

TEMPO-Oxidized Cellulose Beads as Potential pH-Responsive Carriers for Site-Specific Drug Delivery in the Gastrointestinal Tract

The development of controlled drug delivery systems based on bio-renewable materials is an emerging strategy. In this work, a controlled drug delivery system based on mesoporous oxidized cellulose beads (OCBs) was successfully developed by a facile and green method. The introduction of the carboxyl groups mediated by the TEMPO(2,2,6,6-tetramethylpiperidine-1-oxyradical)/NaClO/NaClO₂ system presents the pH-responsive ability to cellulose beads, which can retain the drug in beads at pH = 1.2 and release at pH = 7.0. The release rate can be controlled by simply adjusting the degree of oxidation to achieve drug release at different locations and periods. A higher degree of oxidation corresponds to a faster release rate, which is attributed to a higher degree of re-swelling and higher hydrophilicity of OCBs. The zero-order release kinetics of the model drugs from the OCBs suggested a constant drug release rate, which is conducive to maintaining blood drug concentration, reducing side effects and administration frequency. At the same time, the effects of different model drugs and different drug-loading solvents on the release behavior and the physical state of the drugs loaded in the beads were studied. In summary, the pH-responsive oxidized cellulose beads with good biocompatibility, low cost, and adjustable release rate have shown great potential in the field of controlled drug release.     

Hydrophobically modified alginate for extended release of pharmaceuticals

Hydrophobically modified alginate hydrogels have great potential in drug delivery as they are biologically compatible and cost efficient. While previous works have shown successful protein, and hydrophobic and hydrophilic drug delivery, little information regarding the relationship between crosslinker density and drug release rate is known. This paper investigates the impact of crosslinker density and hydrophobic degree of substitution within modified alginate gels and solutions on the release kinetics using model hydrophobic drug, sulindac. Near zero‐order release was obtained for an extended period of 5 days. Drug release rates decreased as the crosslinker density within both modified alginate hydrogels and solutions increased. Release data fit well to a simplified Fickian relationship, suggesting that the release mechanism is diffusion‐limited. These release characteristics also correlate with bulk rheological measurements, indicating a strong interrelationship between the mechanical properties and the drug release characteristics of the hydrogels.     

Hierarchical Micro/Nanostructures of Natural Polymer for Release Process

In this paper the modeling of drug release process from hierarchical dispersed systems such as nano and microparticles prepared by thermal cross-linking of multiple emulsions is described. The presented model considers the diffusion of a drug through spherical eroding natural polymer matrix and diffusion-convection of the drug in the surrounding medium. Simulated release profiles were compared with experimental data of the drug release from microspheres of various structures. The differences in microspheres structure resulted from changes in mixing intensity of the external surrounding. The simulations of release profiles confirmed the importance of the internal structure of microspheres as well as an intensity of external mixing in the modeling of the controlled release process. The presented model allowed the mass of drug released to be determined with satisfactory agreement with experimental data after optimization of parameters describing internal microspheres structure. The proposed model describing release process of a drug from microspheres can be applied for simulation of release profiles with phasic behavior (primary/lag and continuous release). The model simulations were extended to drug release from nanoparticles with satisfactory results.     

介孔分子筛孔道结构对药物巯甲丙脯酸释放性能的影响

以巯甲丙脯酸为药物模型, 研究了不同孔道结构的介孔分子筛载体的药物释放性能.     

5-氟尿嘧啶在pH敏感型分子筛控释载体中的缓释行为

以肠溶性的羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)作为包覆材料,制备了HPMCP包覆的SBA-15介孔分子筛药物控释载体(HPMCP/SBA-15),并考察了抗癌药物5-氟尿嘧啶(5-Fu)负载于控释载体后,在不同pH释放环境中的释放行为.结果表明,在模拟胃液中(pH=1.2),HPMCP能明显地延缓5-Fu的释放速度;药物释放4h后,其释放率仅为15%.而在模拟肠液中(pH=7.5)HPMCP迅速溶解,对5-Fu释放速度的影响甚微;药物释放4h后,释放率可达到80%.与此同时,包覆膜的干燥温度影响5-Fu的释放行为,干燥温度越高,药物在模拟胃液中的释放速度越慢.     

Mathematical modeling and sustained release property of a 5-fluorouracil imprinted vehicle

In the present research, a type of imprinted hydrogels, in which 5-fluorouracil is complexed non-covalently to the monomers and cross-linked into the hydrogel matrix, is synthesized in order to evaluate the possibility of their applications in sustaining the release of 5-fluorouracil due to the drug’s heightened interactions with the imprinted binding sites. Because of the hydrophility, hydrogels can absorb large amounts of water. As a result, drug release mechanisms are different from hydrophobic polymers. Mathematical model has been established to predict the drug release from the hydrogel matrix as a function of time. The drug release mechanism when immersed in release medium is discussed based on mathematical analysis. Swelling studies are performed and the capability of the hydrogels to reload 5-fluorouracil in aqueous solutions is evaluated. In vitro release studies after reloading are conducted. Mathematical analysis suggest that drug release kinetics from the hydrogels fit Fickian mechanism, further evaluation of the fitness for different hydrogel types reveal that the conformation of binding sites can play a very important role in deciding the kind of drug release mechanism. Experiments reveal that all hydrogels show swelling property. The imprinted hydrogels bind much more 5-fluorouracil than non-imprinted ones, and they sustain 5-fluorouracil release better than non-imprinted hydrogels. This research indicates that the imprinted hydrogels would be a potential promising device for drug delivery.